skip to Main Content

Rucaparib Maintenance Deemed Safe, Effective for Advanced Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
Rucaparib maintenance appears safe and effective for patients with platinum-sensitive, advanced pancreatic cancer and BRCA1/2 or PALB2 variants, according to research published in the Journal of Clinical Oncology.

Researchers conducted a phase 2 trial (ClinicalTrials.gov Identifier: NCT03140670) of rucaparib maintenance in 46 patients with advanced pancreatic cancer who had germline or somatic pathogenic variants in BRCA1, BRCA2, or PALB2. Read more . . . 


Back To Top